
Predictive Oncology (POAI), a biotechnology company specializing in AI-driven cancer research, has announced a $344.4 million digital asset treasury centered...

Predictive Oncology (POAI), a biotechnology company specializing in AI-driven cancer research, has announced a $344.4 million digital asset treasury centered...